Summary of medicine characteristics - WILKO TICKLY COUGH 0.75G/5ML ORAL SOLUTION,BELLS CHILDRENS COUGH SYRUP BLACKCURRANT FLAVOUR,ASDA CHILDRENS DRY COUGH SYRUP GLYCERIN BLACKCURRANT FLAVOUR,HILLS BALSAM CHILDRENS DRY TICKLY COUGH 0.75G/5ML ORAL SOLUTION,ESSENTIAL WAITROSE CHILDRENS DRY
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
2 QUALITATIVE AND QUANTITATIVE COMPOSITIONEach 5ml contains: Glycerol 0.75 gm
3 PHARMACEUTICAL FORM
Oral Solution
4. CLINICAL PARTICULARS
4.1. Therapeutic indications
For the symptomatic relief of tickly coughs and sore throats.
4.2. Posology and method of administration
Adults the Elderly and children over 12 years: 5 to 10ml
Children 6 to 12 years: 5ml
Children 1 to 5 years: 2.5ml
Sip and swallow slowly three or four times a day.
4.3. Contraindications
Hypersensitivity to any of the constituents. Glucose malabsorption syndrome. Glucose intolerance due to sucrase or isomaltase deficiency.
4.4. Special warnings and precautions for use
Keep out of the sight and reach of children.
Shake bottle before use.
Care should be taken in patients with diabetes mellitus.
4.5. Interactions with other medicinal products and other forms of interaction
Citric acid may interact with potassium tartrate, carbonates and bicarbonates which , therefore, should not be administered at the same time.
4.6. Pregnancy and lactation
No data are available.
4.7. Effects on ability to drive and use machines
None.
4.8 Undesirable effects
None Known
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
4.9. Overdose
There is no evidence that overdose is harmful.
5 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
Glycerin is a demulcent and humectant and soothes the throat.
5.2. Pharmacokinetic Properties
Pharmacokinetically glycerin when present in a dosage form such as a syrup will exert its desired action locally on the oro-pharynx.
5.3. Preclinical Safety Data
No relevant information additional to that already contained elsewhere in the SPC.
PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Sucrose
Liquid Glucose
Citric Acid Anhydrous BP
Blackcurrant Flavour
Anthocyanin
Purified Water
6.2. Incompatibilities
None.
6.3. Shelf Life
36 months in unopened bottle.
6.4. Special Precautions for Storage
6.4. Special Precautions for StorageDo not store at a temperature exceeding 25oC. Store in the original container.
6.5 Nature and contents of container
Bottle: White flint or Amber (Type III) glass
Closures: Polypropylene Child resistant closure (CRC) fitted with low density polyethylene EPE/AL/PET liner
OR
Roll on pilfer proof (ROPP) screw cap fitted with low density polyethylene EPE/AL/PET liner
Size: 100 ml, 125 ml, 150 ml, 200 ml.
Not all pack sizes may be marketed
30 ml CE marked polypropylene measuring cup with 2.5 ml, 3.3 ml 4 ml, 5 ml, 7.5 ml, 10 ml, 15 ml, 20 ml and 25 ml graduations.
(May not be included in all marketed products)
6.6. Instruction for Use, Handling and Disposal
None.
MARKETING AUTHORISATION HOLDER
Bell, Sons & Co.
Gifford House
Slaidburn Crescent
Southport
Merseyside
PR9 9AL
8 MARKETING AUTHORISATION NUMBER(S)
PL 03105/0066
9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
29/05/2008